These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 14607000

  • 1. LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.
    Horn CK, Klette KL, Stout PR.
    J Anal Toxicol; 2003 Oct; 27(7):459-63. PubMed ID: 14607000
    [Abstract] [Full Text] [Related]

  • 2. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
    Klette KL, Horn CK, Stout PR, Anderson CJ.
    J Anal Toxicol; 2002 Oct; 26(4):193-200. PubMed ID: 12054358
    [Abstract] [Full Text] [Related]

  • 3. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
    Reuschel SA, Percey SE, Liu S, Eades DM, Foltz RL.
    J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
    [Abstract] [Full Text] [Related]

  • 4. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH, Magluilo J, Shannon KK, Smith ML.
    J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
    Verstraete AG, Van de Velde EJ.
    Acta Clin Belg; 1999 Oct; 53 Suppl 1():94-6. PubMed ID: 10216992
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine.
    Chung A, Hudson J, McKay G.
    J Anal Toxicol; 2009 Jun; 33(5):253-9. PubMed ID: 19671244
    [Abstract] [Full Text] [Related]

  • 9. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
    Poch GK, Klette KL, Hallare DA, Manglicmot MG, Czarny RJ, McWhorter LK, Anderson CJ.
    J Chromatogr B Biomed Sci Appl; 1999 Mar 05; 724(1):23-33. PubMed ID: 10202954
    [Abstract] [Full Text] [Related]

  • 10. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT, George S.
    J Anal Toxicol; 2003 Mar 05; 27(4):249-52. PubMed ID: 12820748
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
    Jang M, Kim J, Han I, Yang W.
    J Pharm Biomed Anal; 2015 Nov 10; 115():138-43. PubMed ID: 26188861
    [Abstract] [Full Text] [Related]

  • 12. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF, Klette KL, Stout PR, Gehlhausen JM.
    J Anal Toxicol; 2002 Oct 10; 26(7):519-23. PubMed ID: 12423010
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
    Dolder PC, Liechti ME, Rentsch KM.
    Anal Bioanal Chem; 2015 Feb 10; 407(6):1577-84. PubMed ID: 25542574
    [Abstract] [Full Text] [Related]

  • 14. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
    Steuer AE, Poetzsch M, Stock L, Eisenbeiss L, Schmid Y, Liechti ME, Kraemer T.
    Drug Test Anal; 2017 May 10; 9(5):788-797. PubMed ID: 27422082
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
    Dolder PC, Liechti ME, Rentsch KM.
    J Clin Lab Anal; 2018 Feb 10; 32(2):. PubMed ID: 28548305
    [Abstract] [Full Text] [Related]

  • 16. Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
    Johansen SS, Jensen JL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct 15; 825(1):21-8. PubMed ID: 16154519
    [Abstract] [Full Text] [Related]

  • 17. LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor.
    Favretto D, Frison G, Maietti S, Ferrara SD.
    Int J Legal Med; 2007 Jul 15; 121(4):259-65. PubMed ID: 16496170
    [Abstract] [Full Text] [Related]

  • 18. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M, Johansen SS, Thomsen R, Linnet K.
    Forensic Sci Int; 2017 Sep 15; 278():e14-e18. PubMed ID: 28803722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.
    Ng XQ, Goh EML, Hamzah A, Yao YJ, Moy HY.
    J Anal Toxicol; 2024 Jun 11; 48(5):281-288. PubMed ID: 38613436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.